3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

Michael Maeng, Hans-Henrik Tilsted, Lisette Okkels Jensen, Anne Kaltoft, Henning Kelbæk, Ulrik Abildgaard, Anton Boel Villadsen, Lars Romer Krusell, Jan Ravkilde, Knud Nørregaard Hansen, Evald Høj Christiansen, Jens Aarøe, Jan Skov Jensen, Steen Dalby Kristensen, Hans Erik Bøtker, Morten Madsen, Per Thayssen, Henrik Toft Sørensen, Leif Thuesen, Jens Flensted Lassen

Research output: Contribution to journalJournal article

34 Citations (Scopus)
Original languageEnglish
JournalJACC. Cardiovascular interventions
Volume5
Pages (from-to)812-8
Number of pages7
ISSN1936-8798
DOIs
Publication statusPublished - 2012
Externally publishedYes

    Fingerprint

Bibliographical note

Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Cite this

Maeng, M., Tilsted, H-H., Jensen, L. O., Kaltoft, A., Kelbæk, H., Abildgaard, U., Boel Villadsen, A., Krusell, L. R., Ravkilde, J., Hansen, K. N., Christiansen, E. H., Aarøe, J., Jensen, J. S., Kristensen, S. D., Bøtker, H. E., Madsen, M., Thayssen, P., Sørensen, H. T., Thuesen, L., & Lassen, J. F. (2012). 3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents. JACC. Cardiovascular interventions, 5, 812-8. https://doi.org/10.1016/j.jcin.2012.04.008